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SUmmAry – The aim is to present our experience and observations regarding varicose vein 
treatment by means of ultrasound guided foam sclerotherapy (UgfS). The study included 81 pati-
ents, 54 with insufficient main stem superficial veins in one limb and 27 with both limbs affected. 
great saphenous vein insufficiency was diagnosed in 68, small saphenous insufficiency in 18, anteri-
or accessory saphenous vein insufficiency in 11, and giacomini vein insufficiency in 3 limbs. Seven 
limbs had combined insufficiency of great saphenous vein and small saphenous vein, and 1 limb had 
combined insufficiency of giacomini vein and small saphenous vein. UgfS was employed to treat 
main stem vein reflux and their tributaries. Within a month after treatment, all main stem veins 
were occluded and only small corrections were performed occasionally to treat residual varices. re-
garding side effects, skin darkening and hard lumps at the sites of varicose veins were most common-
ly observed. We also recorded several episodes of thrombophlebitis. few patients experienced dry 
cough, visual disturbances and headache following the treatment. After six months, repeat UgfS 
of main stem veins had to be performed in few patients. very few patients expressed dissatisfaction 
a year after treatment, mainly because of residual skin darkening. in conclusion, UgfS proved to be 
the simplest, quickest and cheapest method of varicose vein treatment. According to our experience, 
it yielded satisfactory functional and cosmetic results. Side effects do occur, but are acceptable, in 
particular at long term.
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Introduction
endovenous techniques for varicose vein treat-
ment have been implemented since 1999. Although, 
at the beginning, they faced substantial resistance by 
those who were supporting standard methods of vari-
cose vein treatment, such as high ligation and strip-
ping, endovenous techniques have been gaining ever 
more popularity with time and nowadays endovenous 
techniques are widely used and established among the 
methods of choice in treating persons with lower limb 
venous disease1-6.
When speaking about endovenous methods, 
although thermal ablation techniques such as en-
dovenous laser ablation and radiofrequency abla-
tion are considered superior, i.e. more efficient at 
long term, to ultrasound guided foam sclerotherapy 
(UgfS) in treating varicose veins, foam sclerotherapy 
has some substantial advantages over these two meth-
ods, which make it a method of choice in numerous 
circumstances1,3,5,6.
The aim of this article is to present our results in 
UgfS of lower limb varicose veins caused by main 
stem vein insufficiency and to discuss its advantages 
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over other methods of varicose vein treatment, as well 
as its drawbacks. 
Patients and Methods
from October 2011 until January 2013, we treated 
108 lower limbs with varicose veins caused by main 
stem vein reflux by use of UgfS. inclusion criteria 
were superficial venous insufficiency of lower limbs 
caused by main stem vein insufficiency, as confirmed 
on duplex scanning, with patent and competent deep 
veins, in patients who agreed to undergo UgfS and 
signed the informed consent form. 
The informed consent form provided the following 
information: primary success rate in main stem vein 
closure of 95%-100%; 77% success rate after 3 years; 
and possible complications or side effects including 
deep venous thrombosis and pulmonary embolism, 
dry cough, visual disturbances, headaches, cerebral 
ischemic attacks, hard lumps which tend to with-
draw with time, hyperpigmentation and discoloration 
which tend to fade with time, and thrombophlebitis 
episode7-10.
exclusion criteria were patients with obstructed or 
incompetent deep veins, if confirmed on duplex scan-
ning, patients on anticoagulation therapy which could 
not be ceased, hypercoagulable states, such as previous 
history of deep venous thrombosis and/or pulmonary 
embolism, severe thrombophilia, etc.7-10. 
We also excluded from the study patients who 
had insufficient superficial veins, but other than main 
stem veins (i.e. other than great saphenous vein, small 
saphenous vein, anterior accessory saphenous vein, 
or giacomini vein). These were, e.g., patients who 
suffered from varicose veins due to perforating vein 
reflux, patients who suffered from varicose veins or 
reticular veins without main stem vein insufficiency, 
patients with venous malformations, such as Klippel-
trénaunay syndrome, etc.
Based on duplex scanning, we included 81 patients 
in the study. fifty-four of them had insufficient su-
perficial veins in one limb, whereas 27 had both lower 
limbs affected with incompetent main stem superfi-
Fig. 1. Location of cannulas and amounts of foam for 
treatment of great saphenous vein reflux.
Fig. 2. Location of cannulas and amounts of foam for 
treatment of small saphenous vein reflux.
Fig. 3. Location of cannulas and amounts of foam for 
treatment of anterior accessory saphenous vein reflux.
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cial veins. in 68 limbs, we diagnosed great saphen-
ous insufficiency solely, in 18 limbs small saphenous 
insufficiency, in 11 limbs anterior accessory saphen-
ous vein insufficiency, and in 3 limbs giacomini vein 
insufficiency. Seven limbs had combined insufficiency 
of great saphenous vein and small saphenous vein, and 
1 limb had combined insufficiency of giacomini vein 
and small saphenous vein. 
in all patients, both main stem veins and their 
tributaries were first cannulated under ultrasound 
guidance using intravenous cannulas (figs. 1-3). 
tributaries were first treated by injection of 1% or 2% 
polidocanol foam (Aethoxysklerol, Kreussler Pharma, 
Wiesbaden, germany). After that, main stem vein 
was treated by administration of 3% Aethoxysklerol 
foam (figs. 1-3). no anesthesia was applied7-10.
in all patients, foam was prepared by mixing liquid 
Aethoxysklerol with air at 1:4 ratio in 5 ml syringes, 
using 3-way stopcock, according to tessari technique7-
10.  We did not administer more than 18 ml of foam 
per session7-10. if this amount could not solve the en-
tire problem, e.g., in some of the patients who had 
varicose veins in both legs, or in some of the patients 
with more than one insufficient main stem vein in one 
leg, we stopped the treatment and continued a week 
later. All patients were provided compression class 2 
stockings and were asked to wear them for the first 
3 days day and night, and, after that, for the next 4 
weeks during the day solely. They were also asked to 
ambulate for half an hour after leaving the clinic, and 
for the next 2 days 3 times a day for 20-30 minutes. 
They were advised to treat possible tender or painful 
areas by local application of diclofenac gel or to take 
anti-inflammatory analgesic pills such as paracetamol, 
diclofenac, or ibuprofen.
All included patients underwent follow up within 
2-4 weeks after the treatment by means of duplex 
scanning; they were examined at around day 19 of the 
procedure (17-21.25 interquartile range).
Results
At follow up, we reexamined venous system with 
duplex ultrasound: all patients had patent deep veins 
and closed treated main stem veins, as well as most of 
their tributaries (figs. 4-7). however, in a great deal 
of patients, we performed some smaller corrections 
such as additional UgfS of the residual, un-obliter-
Fig. 4.  Varicose veins caused by great saphenous vein 
insufficiency before and within a month after treatment. 
Some skin darkening is still present.
Fig. 5. Varicose veins caused by small saphenous vein in-
sufficiency before and within a month after treatment. In 
this case, practically no side effects, such as skin darkening 
and hard lumps, were noticed.
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ated varicose tributaries with smaller or intermediate 
amounts of foam (up to 8 ml of 1% or 2% Aethox-
ysklerol foam) and/or aspiration of trapped blood from 
the treated veins using 18-19 g needle and 5 ml sy-
ringe. The latter was employed in cases where residual 
hard lumps were still bulging, painful and hypoechoic 
on ultrasound.
Since patients were not asked to present for further 
follow up unless they wanted to, we could not review 
the short and long term results systematically, but ac-
cording to our observations, we did not have to under-
go unpleasant events related to patient dissatisfaction 
or disappointment in a year and a half period after the 
study had been conducted. Some patients visited us to 
do residual or recurrent varicose veins, but it could be 
easily managed by reemployment of UgfS. in such 
cases, we occasionally used sodium tetradecyl sulfate 
foam (fibrovein, Std Pharmaceuticals, hereford, 
United Kingdom), since it is considered a stronger de-
tergent sclerosant than polidocanol (Aethoxysklerol). 
Such approach usually achieved permanent oblitera-
tion of veins8-10. We avoided using stronger detergent 
sclerosant (sodium tetradecyl sulfate) primarily in or-
der to reduce possible complications. Philip Coleridge 
Smith, who employed a similar technique as we did, 
has reported an occlusion rate of 88% six months after 
the treatment of great saphenous vein reflux and 83% 
after the treatment of small saphenous vein reflux8,10.
The only residual adverse events still present at ≥6 
month follow up were skin pigmentation and palpable 
lumps (figs. 4, 6 and 7). The skin pigmentation was 
almost always of a minor extent and continued to fade 
with the passage of time (fig. 7). however, it was still 
occasionally seen even a year after the treatment, and 
there were some (although rather rare) patients who 
expressed dissatisfaction with treatment results.
regarding other adverse effects, we noticed dry 
cough immediately after the treatment in three pa-
tients and visual disturbances in one patient, which 
both resolved within 20 minutes. One patient report-
ed severe headache the day after the treatment and she 
was advised to use diclofenac pills for pain alleviation. 
Occasionally, patients complained of thrombophle-
bitic episodes, i.e. painful, tender and swollen treated 
veins and surrounding areas, usually within a week 
after the treatment; they were also advised to use anti-
inflammatory pain killers (paracetamol, diclofenac, or 
ibuprofen) and to take a day or two off work in order 
to relax. hot dressings were also advised to be applied 
on painful areas8-10.  
Discussion
According to our results and the results reported 
in the literature8-10, foamed sclerosant ablation proved 
to be a safe and, at shorter/middle terms, very effective 
treatment for varicose veins, which resulted from the 
main stem vein reflux. At longer terms (3-year follow 
up), according to the literature, success rate for strip-
Fig. 6. Varicose veins caused by anterior accessory saphen-
ous vein insufficiency on both legs before and within a 
month after treatment. In this case, we treated both legs 
in one session.
Fig. 7. Varicose veins caused by Giacomini vein insuffi-
ciency before, 1 month, and 12 months after treatment. It 
is obvious that residual skin darkening fades with time.
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ping, foam sclerotherapy, radiofrequency ablation and 
laser therapy was 78%, 77%, 84% and 94%, respec-
tively3. 
Although thermal ablation with laser or radiof-
requency currently competes successfully with foam 
for treatment of saphenous veins, and ambulatory 
phlebectomy competes with foam for treatment of 
tributary veins and localized varicosities, especially 
when these are large1-6, the advantages of foam scle-
rotherapy over these procedures are as follows: there 
is no need for high-tech expensive equipment, such as 
laser, or radiofrequency; there is no need for any kind 
of anesthesia; it is simpler to perform since passing 
with laser or radiofrequency catheter through insuf-
ficient veins can be hard, especially if these are tortu-
ous. Besides, superficial veins are prone to vasospasm, 
which can, in particular in inexperienced hands, bring 
up to complete impossibility to perform endovenous 
laser or radiofrequency ablation4. When compared 
with ambulatory phlebectomy, the advantage of foam 
is that there is no need to be trained in this microsur-
gical procedure, which, in particular in inexperienced 
hands, can bring to complications such as bleeding, 
scarring or pain during the procedure, or even infec-
tion. in contrast to traditional surgery, no scars, neu-
rologic damage or lymphatic injuries can occur8-10.
Besides, the usage of foam is much cheaper than 
thermal ablation techniques and cheaper than tradi-
tional surgery; e.g., in great Britain, the average cost 
per procedure for sclerosant agent, surgical stripper, 
laser optic fiber, and radiofrequency ablation catheter, 
according to Carrol et al., would be £ 5-10, £ 10-20, 
£ 200-300 and £ 460-578, respectively11. The cost of 
laser generator would be some £ 20,000, and the cost 
of radiofrequency generator some £ 10,00011 (these 
costs in Croatia do not differ significantly from those 
in Britain). Additional savings with endovenous tech-
niques in comparison with surgery are as follows: there 
is no need for patient hospitalization; it is sufficient to 
use solely local anesthesia or, in case of UgfS, one 
can work without any anesthesia; sick leaves are much 
shorter; there are savings in staff engagement, etc.11.
Sclerotherapy is chemical ablation of abnormal 
veins. The goal of therapy is irreversible fibrotic oc-
clusion, followed by reabsorption of the target vessel. 
Absence of endothelium and subendothelial edema 
are seen within 2 minutes of foam injection. At 15 
minutes, necrosis of the vein wall into the tunica me-
dia is seen12.
Sclerotherapy is an old technique that has been 
revolutionized by recent technological advances7-10. 
foaming detergent sclerosants such as polidocanol 
(Aethoxysklerol) or sodium tetradecyl sulfate (fi-
brovein) offer increased patency and could be visual-
ized by means of ultrasonography. Ultrasound guid-
ance allows for better anatomic visualization, greater 
hemodynamic understanding, more precise foam 
targeting and delivery, and monitoring for unwant-
ed foam passage into deep veins in greater amounts. 
With these advances, sclerotherapy has now become a 
competitive treatment for any type or size of vein8-10.
however, possible complications, local and sys-
temic, still have to alert the potential practitioner to 
be cautious. Systemic complications, such as brain 
ischemia or deep venous thrombosis represent the big-
gest threat. Although episodes of brain ischemia have 
been reported in the literature, we have not experi-
enced any. Besides, all cases reported in the literature 
have successfully recovered, and, to our knowledge, 
no tragic cases with permanent neurologic deficit have 
been reported1,3,8-10. According to the literature, deep 
venous thrombosis occasionally occurs, but it is usu-
ally of minor extent and resolves with anticoagulation 
therapy, compression stockings, and exercise8-10. dry 
cough as a side effect occurring immediately after 
the treatment may be associated with the maximum 
volume of foam of 18 ml. According to the german 
Society of Phlebology, the volume of foam is limited 
to a maximum of 10 ml per session13, but according 
to British and American authors, larger amounts of 
foam (up to 20 ml per session) can be administered10. 
Besides, there is evidence that the use of carbon diox-
ide (CO2) foam reduces the number of post-treatment 
episodes of visual disturbances and coughing10. CO2 
is much more soluble in blood and water than nitro-
gen (in air) and is less likely to travel to more distant 
organs10. however, it seems that the classic tessari 
technique, i.e. mixing sclerosant with air, still pre-
vails10. (These two side effects are probably due to 
the presence of foam in lungs and orbital vessels; it is 
believed that they might be avoided or diminished if 
the patient lies supine for some 20-30 minutes after 
treatment, ref. 10). local complications such as hard 
tender lumps, or even thrombophlebitis pose a smaller 
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threat, but can still upset the patient in a great measure 
and bring the physician in an unfavorable position, i.e. 
in need to reassure the patient that everything is hap-
pening according to the pre-treatment plan. Patients 
sometimes can ask other practitioners for help, and 
these, in particular if not familiar with this method, 
may employ unnecessary anticoagulation therapy or 
antibiotics. The commonest side effect is skin darken-
ing (ref. 8-10, figs. 4, 6 and 7), which, in our experi-
ence, affects most of the treated patients to a smaller 
or greater extent. it does tend to fade and withdraw 
with time (ref. 8-10, fig. 7), but in a smaller number 
of patients it can last for more than a year and some 
patients may finally express disappointment. There-
fore, it is recommended to take photos of varicose vein 
status14 before treatment and at follow up sessions in 
order to be able to present them to the patients in case 
of complaints. Skin darkening itself also occurs after 
laser ablation and surgery, but is significantly more 
frequent after foam sclerotherapy and is likely to im-
pair the patient quality of life15. According to Smith, 
it was seen in 115 of 457 limbs after 6 months and in 
11 of 115 limbs after 1 year10.    
to conclude, UgfS is easy to perform and is a 
patient and physician friendly, inexpensive, quick, 
simplest and least invasive method to solve lower limb 
superficial venous disease. it has clear advantages over 
other methods, such as endovenous laser and radiofre-
quency ablation, ambulatory phlebectomy, and classic 
surgery, i.e. stripping. however, this method has its 
disadvantages, i.e. side effects, which both the patient 
and the physician have to be aware of. Patients and 
physicians alike should be familiar with pros and cons 
regarding UgfS and other methods before making 
final decision on which method of varicose vein treat-
ment to employ.
Since UgfS can also be performed to treat other 
vascular alterations16, such as bulging hand veins, vas-
cular malformations, etc., further papers are welcome 
to clarify the possibilities and disadvantages of UgfS 
in such circumstances. 
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Sažetak
UltrAZvUČnO vOĐenA SKlerOZACiJA PJenOm – nAJJednOStAvniJA, nAJmAnJe 
invAZivnA i nAJJeftiniJA metOdA liJeČenJA PrOŠirenih venA
A. Krnić
Cilj ovoga rada je prikazati naša iskustva i mišljenja vezano za liječenje proširenih vena upotrebom ultrazvučno vođene 
sklerozacije pjenom (engl. ultrasound guided foam sclerotherapy, UgfS). U studiju smo uključili 81 bolesnika: 54 s insufi ci-
jentnim površinskim venama glavnog stabla u jednoj nozi i 27 bolesnika kod kojih su bile zahvaćene obje noge. U 68 nogu 
dijagnosticirali smo insuficijenciju vene safene magne (lat. vena saphena magna), u 18 vene safene parve (lat. vena saphena 
parva), u 11 anteriorne akcesorne safenske vene, a u 3 noge insuficijenciju giacominijeve vene. Sedam nogu imalo je kom-
biniranu insuficijenciju vene safene magne i vene safene parve, a 1 noga kombiniranu insuficijenciju giacominijeve vene 
i vene safene parve. Koristili smo UgfS da bismo liječili insuficijenciju u venama glavnog stabla, kao i u njihovim prito-
cima. Unutar mjesec dana nakon tretmana sve vene glavnog stabla bile su okludirane te su bile potrebne samo povremene 
manje korekcije u smislu tretmana rezidualnih varikoziteta. Što se tiče nuspojava, najčešće smo znali uočiti zatamnjenja 
kože i tvrde grudice na mjestima varikoznih vena. također smo uočili i nekoliko epizoda tromboflebitisa. vrlo malo bole-
snika imalo je suhi kašalj, smetnje vida i glavobolje nakon tretmana. Kod malog broja bolesnika trebalo je ponoviti UgfS 
na venama glavnog stabla nakon 6 mjeseci. vrlo malo bolesnika iskazivalo je nezadovoljstvo godinu dana nakon tretmana, 
uglavnom zbog rezidualnih zatamnjenja kože. U zaključku, UgfS se pokazala kao najjednostavnija, najbrža i najjeftinija 
metoda liječenja proširenih vena. Prema našim iskustvima, ova metoda postiže zadovoljavajuće funkcionalne i kozmetske 
rezultate. nuspojave se mogu javiti, ali su prihvatljive, osobito gledajući dugoročno.
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